✦ LIBER ✦

371 Phase 2 randomized discontinuation trial (RDT) of XL184 in patients (pts) with advanced solid tumors

✍ Scribed by P. Schöffski; M. Sgroi; H.A. Burris; J. Lutzky; T. Rearden; B. Sikic; J. Stephenson Jr.; D. Elhardt; Y. Lee; R. Kurzrock

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

398 Phase 2 results of XL184 in a cohort

✍ H. Nechushtan; G. Edelman; G. Jerusalem; M. Gordon; H.M. Kluger; A. Moussa; I. R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase I trial with farnesyltransferase i

✍ Punt, C.J.A.; Peters, M.; van Maanen, L.; van de Walle, B.; Bol, C.; Willems, L. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 143 KB

397 Phase 2 results of XL184 in a cohort

✍ C. Yasenchak; K. Nackaerts; A. Awada; S.M. Gadgeel; B. Hellerstedt; M.C. Perry; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

A phase I trial of perillyl alcohol in p

✍ Christopher G. Azzoli; Vincent A. Miller; Kenneth K. Ng; Lee M. Krug; David R. S 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 232 KB

228 A phase I trial of LY573636 in patie

✍ G. Simon; M. Sovak; M. Wagner; E. Haura; S. Gerst; D. deAlwis; G. Bepler; D. Sul 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Phase I trial of sunitinib and gemcitabi

✍ Joanna M. Brell, Smitha S. Krishnamurthi… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 177 KB